Heung Macy M S, Jin Shengnan, Tsui Nancy B Y, Ding Chunming, Leung Tak Y, Lau Tze K, Chiu Rossa W K, Lo Y M Dennis
Centre for Research into Circulating Fetal Nucleic Acids, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region, China.
PLoS One. 2009 Jun 10;4(6):e5858. doi: 10.1371/journal.pone.0005858.
Placental mRNA was detected in maternal whole blood, raising the possibility of using maternal blood for noninvasive prenatal diagnosis. We investigated fetal mRNA detection in maternal whole blood and determined if it offered advantages over maternal plasma analysis.
The concentrations of placental expressed genes, CSH1, KISS1, PLAC4 and PLAC1 in plasma and whole blood from healthy pregnant and non-pregnant individuals were compared by real-time quantitative reverse-transcriptase polymerase chain reaction analysis. Their fetal specificity was investigated by comparing the transcript concentrations in pre- and post-delivery samples and through SNP genotyping by matrix-assisted laser-desorption and ionization time-of-flight mass spectrometry. The gene expression profiles of pregnant and non-pregnant whole blood were investigated by microarray analysis. Upregulated genes in pregnant whole blood were selected for further quantitative analysis.
The concentrations of the four transcripts were significantly higher in third trimester maternal whole blood than corresponding plasma without significant correlations. KISS1, PLAC4 and PLAC1 were detected in non-pregnant whole blood but not plasma. The transcripts remained detectable in some postpartum whole blood samples. The PLAC4 mRNA in maternal plasma showed fetal genotype while that in corresponding whole blood indicated both fetal and maternal contributions. Microarray analysis revealed upregulation of genes involved in neutrophil functions in pregnant whole blood including DEFA4, CEACAM8, OLFM4, ORM1, MMP8 and MPO. Though possibly pregnancy-related, they were not pregnancy-specific as suggested by the lack of post-delivery reduction in concentrations.
Maternal plasma is preferred over maternal whole blood for placenta-derived fetal RNA detection. Most studied 'placental' mRNA molecules in maternal whole blood were of maternal origin and might be derived from processes such as 'illegitimate transcription'.
在母体全血中检测到胎盘mRNA,这增加了利用母体血液进行无创产前诊断的可能性。我们研究了在母体全血中检测胎儿mRNA,并确定其是否比母体血浆分析具有优势。
通过实时定量逆转录聚合酶链反应分析,比较健康孕妇和非孕妇血浆及全血中胎盘表达基因CSH1、KISS1、PLAC4和PLAC1的浓度。通过比较分娩前和分娩后样本中的转录本浓度,并通过基质辅助激光解吸电离飞行时间质谱进行SNP基因分型,研究它们的胎儿特异性。通过微阵列分析研究孕妇和非孕妇全血的基因表达谱。选择孕妇全血中上调的基因进行进一步定量分析。
孕晚期母体全血中四种转录本的浓度显著高于相应血浆,且无显著相关性。在非孕妇全血中检测到KISS1、PLAC4和PLAC1,但在血浆中未检测到。在一些产后全血样本中仍可检测到这些转录本。母体血浆中的PLAC4 mRNA显示胎儿基因型,而相应全血中的PLAC4 mRNA显示胎儿和母体的共同贡献。微阵列分析显示孕妇全血中参与中性粒细胞功能的基因上调,包括DEFA4、CEACAM8、OLFM4、ORM1、MMP8和MPO。尽管可能与妊娠相关,但由于浓度在分娩后没有降低,它们并非妊娠特异性。
在检测胎盘来源的胎儿RNA方面母体血浆优于母体全血。在母体全血中研究的大多数“胎盘”mRNA分子来源于母体,可能来自“异常转录”等过程。